CHRS
COHERUS ONCOLOGY INC
Latest close $1.47 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 5 parsed filing(s) · 2 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 27, 2026 filed · 27d Initial Schedule 13G | Initial Schedule 13G | 8.9M +1.6M | 12.00% 0.00 pts | $1.40 | $1.46 | $1.47 |
| BlackRock CIK0002012383 | Mar 31, 2026 observed Apr 27, 2026 filed · 27d Schedule 13G amendment | Earliest Schedule 13G amendment found | 7.3M | 12.00% | $1.69 | $1.84 | $1.47 |
| BlackRock CIK0002012383 | Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 12.0M | $1.47 |